Epiblox Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$20K
- Investors
-
1
Epiblox General Information
Description
Developer of pharmaceutical treatments designed for severe childhood epilepsy. The company is advancing a drug candidate targeting treatment-resistant epilepsy, using novel mechanisms of action and clinical validation, enabling the pediatric healthcare market to access alternative therapeutic options for improving outcomes in children with limited response to existing medications.
Contact Information
Corporate Office
- Melbourne, Victoria
- Australia
Corporate Office
- Melbourne, Victoria
- Australia
Epiblox Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 10-Apr-2025 | $20K | Completed | Startup |
Epiblox Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CSIRO ON Accelerate | Accelerator/Incubator | Minority |
Epiblox FAQs
-
Where is Epiblox headquartered?
Epiblox is headquartered in Melbourne, Australia.
-
What industry is Epiblox in?
Epiblox’s primary industry is Drug Discovery.
-
Is Epiblox a private or public company?
Epiblox is a Private company.
-
What is Epiblox’s current revenue?
The current revenue for Epiblox is .
-
How much funding has Epiblox raised over time?
Epiblox has raised $20K.
-
Who are Epiblox’s investors?
CSIRO ON Accelerate has invested in Epiblox.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process